N/A N=32 Randomized Single-blind Treatment

Effectiveness of Astym Treatment For de Quervain's Tenosynovitis

de Quervain's Disease

Bottom Line

View on ClinicalTrials.gov: NCT02442622 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2020

Primary outcome: Primary: Numeric Rating Scale for Pain — 3.2; 2.1 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Occupational therapy (Other); Occupational therapy with ASTYM (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: NYU Langone Health
Primary completion: Apr 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Numeric Rating Scale for Pain	3.2; 2.1	—
SECONDARY Sequential Occupational Dexterity Assessment (SODA) Score	107.33; 106.75	—
SECONDARY Quick Dash Score	4.72; 10.61	—

Summary

To determine if the addition of Astym treatment to traditional therapy produces a more positive outcome then traditional therapy alone for the treatment of de Quervain's tenosynvitis. Two groups will be examined with one group receiving traditional therapy and the other group receiving traditional therapy in addition to Astym treatment protocol.

Eligibility Criteria

Inclusion Criteria

i. Positive Finkelstein's test: The client will report pain over the first compartment of the extensor retinaculum when the thumb is tucked in the hand and deviated ulnarly.

ii. Persistent symptoms for >3 wks which have not resolved after an additional 3 weeks of splinting

iii. A diagnosis by a physician of "de Quervain's", "fist compartment tenosynovitis", or "radial styloid tenosynovitis"

iv. Patients must agree and comply to a predetermined splinting regimen

Exclusion Criteria

i. History of cortical steroid injection to affected wrist and/or thumb

ii. History of previous wrist trauma to affected limb

iii. Comorbidity such as carpal tunnel syndrome (CTS), radial tunnel syndrome, osteoarthritis, rheumatoid arthritis, auto-immune disease or inflammatory conditions, lateral epicondylitis or tendinopathies

iv. Clotting deficits

v. Positive Cozen's sign which would indicate intersection syndrome

vi. Post-partum mothers <6 months and pregnant women

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02442622). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.